<DOC>
	<DOCNO>NCT00006479</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug combine chemotherapy surgery may kill tumor cell . It yet know surgery effective without chemotherapy liver metastasis . PURPOSE : Randomized phase III trial compare effectiveness surgery without combination chemotherapy treat patient liver metastasis colorectal cancer .</brief_summary>
	<brief_title>Surgery With Without Combination Chemotherapy Treating Patients With Liver Metastases From Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare progression-free overall survival patient resectable colorectal liver metastasis treat surgery without neoadjuvant adjuvant oxaliplatin , fluorouracil , leucovorin calcium . - Compare percentage patient total resection two treatment . OUTLINE : This multicenter study . Patients stratify accord participate center , prior adjuvant chemotherapy ( yes v ) , plasma CEA level ng/mL diagnosis liver metastasis ( 5 less v 6 30 v 31 great ) , serosa extension primary cancer ( absent T1 T2 v present T3 T4 ) , lymphatic spread primary cancer ( absent v present N+ ) , time interval diagnosis primary tumor metastasis ( 2 year vs few 2 year ) , number metastasis ( 1 3 v 4 ) . Patients randomize one two treatment arm . - Arm I : Patients receive oxaliplatin IV 2 hour day 1 leucovorin calcium ( LV ) IV 2 hour follow fluorouracil ( 5-FU ) IV 22 hour day 1 2 . Treatment repeat every 15 day 6 course absence disease progression unacceptable toxicity . At 2 5 week chemotherapy , patient undergo liver resection . Patients progressive disease 3 course chemotherapy undergo liver resection least 2 week completion course 3 receive postoperative chemotherapy . At 2 5 week surgery , patient receive oxaliplatin , LV , 5-FU preoperative chemotherapy . - Arm II : Patients undergo liver resection . Patients follow every 3 month 2 year every 6 month thereafter . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : A total 330 patient ( 165 per arm ) accrue study within 3 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis potentially resectable colorectal liver metastasis meet one follow criterion : Metachronous metastasis complete resection primary tumor without gross microscopic evidence residual disease Synchronous metastases complete resection primary tumor 1 month study Synchronous metastases sufficient evidence ( i.e. , CAT scan diagnostic laparoscopy ) primary tumor liver metastases completely resected procedure resection primary may delay 34 month PATIENT CHARACTERISTICS : Age : 18 80 Performance status : WHO 02 Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Absolute neutrophil count great 1,500/mm^3 Platelet count great 100,000/mm^3 Hepatic : No hepatic insufficiency Renal : Creatinine le 2 time upper limit normal Cardiovascular : No uncontrolled congestive heart failure angina pectoris No hypertension arrhythmia Other : No malignancy within past 10 year except adequately treat carcinoma situ cervix nonmelanoma skin cancer No peripheral neuropathy great grade 1 No prior significant neurologic psychiatric disorder No active infection Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent biologic therapy Chemotherapy : No prior chemotherapy advance disease Prior adjuvant chemotherapy primary cancer allow unless include oxaliplatin No concurrent chemotherapy Endocrine therapy : No concurrent anticancer endocrine therapy Radiotherapy : No concurrent radiotherapy Surgery : See Disease Characteristics Other : At least 30 day since prior investigational drug No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2000</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>liver metastasis</keyword>
</DOC>